Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Mar 22, 2011

Premium

Phalanx Biotech Group last week launched its Rat Whole Genome OneArray for gene expression profiling.

The chip's content is curated from the RefSeq and Ensembl databases. It includes 25,338 long oligonucleotide probes engineered to meet isothermal requirements for hybridization performance. Phalanx claims the chip offers "high correlation" with quantitative PCR. The Taiwanese firm added that the array enables the interrogation of pathways observed in rat disease models and animal drug metabolism and pharmacokinetics studies.


Skyline Diagnostics last week launched its AMLprofiler for clinical use in Europe.

The test, which runs on the Affymetrix GeneChip platform, allows users to classify individual acute myeloid leukemia patients into different risk categories. Within four days, AMLprofiler can identify AML subtypes in order to help clinicians select the appropriate method of treatment, Skyline said.

BioArray News spoke with Skyline officials about the test last week (BAN 3/15/2011).

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.